MML Investors Services
GSK icon

MML Investors Services’s GSK GSK Stock Holding History

MML Investors Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Buy
246,909
+80,540
+48% +$4.26M 0.03% 546
2026
Q1 		$9.18M Sell
166,369
-135,208
-45% -$7.33M 0.03% 568
2025
Q4 		$14.8M Sell
301,577
-4,962
-2% -$231K 0.04% 445
2025
Q3 		$13.2M Sell
306,539
-22,203
-7% -$867K 0.04% 460
2025
Q2 		$12.6M Buy
328,742
+93,883
+40% +$3.59M 0.04% 448
2025
Q1 		$9.1M Buy
234,859
+20,584
+10% +$754K 0.03% 502
2024
Q4 		$7.25M Sell
214,275
-1,903
-0.9% -$68.5K 0.03% 563
2024
Q3 		$8.84M Buy
216,178
+10,067
+5% +$412K 0.03% 465
2024
Q2 		$7.93M Sell
206,111
-23,808
-10% -$1M 0.03% 474
2024
Q1 		$9.86M Buy
229,919
+10,440
+5% +$431K 0.04% 415
2023
Q4 		$8.13M Buy
219,479
+23,009
+12% +$826K 0.04% 437
2023
Q3 		$7.12M Buy
196,470
+65,102
+50% +$2.31M 0.04% 419
2023
Q2 		$4.68M Buy
131,368
+43,260
+49% +$1.55M 0.03% 560
2023
Q1 		$3.13M Buy
88,108
+3,049
+4% +$107K 0.02% 614
2022
Q4 		$2.99M Buy
85,059
+5,171
+6% +$172K 0.02% 665
2022
Q3 		$2.35M Buy
79,888
+19,100
+31% +$724K 0.02% 695
2022
Q2 		$3.31M Buy
60,788
+9,251
+18% +$511K 0.03% 556
2022
Q1 		$2.81M Buy
51,537
+6,410
+14% +$348K 0.02% 663
2021
Q4 		$2.49M Sell
45,127
-1,963
-4% -$102K 0.02% 677
2021
Q3 		$2.25M Buy
47,090
+7,938
+20% +$399K 0.02% 677
2021
Q2 		$1.95M Buy
39,152
+10,645
+37% +$511K 0.02% 721
2021
Q1 		$1.27M Sell
28,507
-554
-2% -$25.1K 0.01% 822
2020
Q4 		$1.34M Sell
29,061
-40,340
-58% -$1.85M 0.01% 721
2020
Q3 		$3.27M Sell
69,401
-4,211
-6% -$211K 0.04% 371
2020
Q2 		$3.75M Sell
73,612
-9,610
-12% -$493K 0.05% 321
2020
Q1 		$3.94M Sell
83,222
-10
-0% -$533 0.07% 262
2019
Q4 		$4.89M Buy
83,232
+1,477
+2% +$82.2K 0.07% 264
2019
Q3 		$4.36M Sell
81,755
-16,891
-17% -$869K 0.07% 265
2019
Q2 		$4.93M Buy
98,646
+1,452
+1% +$72.9K 0.07% 265
2019
Q1 		$5.08M Buy
97,194
+3,853
+4% +$193K 0.08% 244
2018
Q4 		$4.46M Sell
93,341
-467
-0.5% -$23K 0.08% 259
2018
Q3 		$4.71M Buy
93,808
+25,549
+37% +$1.3M 0.08% 244
2018
Q2 		$3.44M Buy
68,259
+1,529
+2% +$77K 0.08% 250
2018
Q1 		$3.26M Sell
66,730
-3,617
-5% -$168K 0.07% 251
2017
Q4 		$3.12M Sell
70,347
-2,011
-3% -$92.9K 0.06% 255
2017
Q3 		$3.67M Buy
72,358
+5,028
+7% +$255K 0.08% 219
2017
Q2 		$3.63M Buy
67,330
+4,274
+7% +$228K 0.07% 215
2017
Q1 		$3.32M Buy
+63,056
New +$3.2M 0.07% 104

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

MML Investors Services's GSK Position: Q2 2026 in Review

MML Investors Services increased its GSK (GSK) stake by 48% in Q2 2026, buying an estimated $4.26M and bringing the position to 246,909 shares worth $12.9M. The position accounts for 0.03% of the portfolio, ranked #546.

MML Investors Services first reported a position in GSK in Q1 2017 and has held it in 38 quarters since. The position peaked at $14.8M in Q4 2025. 627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • MML Investors Services held 246,909 shares of GSK worth $12.9M as of Q2 2026.
  • MML Investors Services bought 80,540 GSK shares in Q2 2026, an estimated $4.26M.
  • GSK made up 0.03% of MML Investors Services's portfolio in Q2 2026, its #546 holding.
  • MML Investors Services first reported a position in GSK in Q1 2017 and has held it in 38 quarters since.
  • MML Investors Services's GSK position peaked at $14.8M in Q4 2025.
  • 627 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.